News

Pharmabiz2m

Trailhead Biosystems expands iPSC-derived portfolio with TrailBio Hematopoietic Progenitor Cells

Trailhead Biosystems expands iPSC-derived portfolio with TrailBio Hematopoietic Progenitor Cells: Beachwood, Ohio Wednesday, August 6, 2025, 16:00 Hrs [IST] Trailhead Biosystems, ...
Pharmabiz17m

KDPMA elects Jatish N Sheth as president for the term 2025 to 2027

KDPMA elects Jatish N Sheth as president for the term 2025 to 2027: Our Bureau, Bengaluru Wednesday, August 6, 2025, 15:45 Hrs [IST] Karnataka Drugs and Pharmaceuticals Manufactur ...
Pharmabiz1h

US FDA clears Hemispherian’s IND application for first-in-class glioblastoma therapeutic, GLIX1

US FDA clears Hemispherian’s IND application for first-in-class glioblastoma therapeutic, GLIX1: Oslo, Norway Wednesday, August 6, 2025, 15:00 Hrs [IST] Hemispherian AS, a pione ...
Pharmabiz1h

Lupin reports 51.5 per cent growth in net profit during Q1FY26

Lupin reports 51.5 per cent growth in net profit during Q1FY26: Our Bureau, New Delhi Wednesday, August 6, 2025, 14:30 Hrs [IST] Lupin Ltd has posted a growth of 51.5 per cent in ...
Pharmabiz1h

Medistep Healthcare's IPO to open on August 8; Issue price fixed at Rs. 43 per share

Medistep Healthcare's IPO to open on August 8; Issue price fixed at Rs. 43 per share: Our Bureau, Mumbai Wednesday, August 6, 2025, 14:15 Hrs [IST] Medistep Healthcare Limited, a ...
Pharmabiz2h

Innovent Biologics receives US FDA clearance to initiate phase 1 clinical trial of novel oral GLP-1R agonist, IBI3032

Innovent Biologics receives US FDA clearance to initiate phase 1 clinical trial of novel oral GLP-1R agonist, IBI3032: San Francisco Wednesday, August 6, 2025, 14:00 Hrs [IST] Inn ...
Pharmabiz2h

Laborate Pharmaceuticals secures EU-GMP certification, expands global supply chain capabilities

Laborate Pharmaceuticals secures EU-GMP certification, expands global supply chain capabilities: Our Bureau, Mumbai Wednesday, August 6, 2025, 13:30 Hrs [IST] Laborate Pharmaceuti ...
Pharmabiz3h

SOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes

SOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes: Boston Wednesday, August 6, 2025, 13:00 Hrs [IST] SOPHiA GENETICS, a clo ...
Pharmabiz4h

US FDA accepts for priority review Bristol Myers Squibb’s sBLA for Breyanzi to treat adult patients with relapsed or refractory MZL

US FDA accepts for priority review Bristol Myers Squibb’s sBLA for Breyanzi to treat adult patients with relapsed or refractory MZL: Princeton, New Jersey Wednesday, August 6, 2 ...
Pharmabiz5h

Polpharma Biologics & Fresenius Kabi enter licensing agreement for proposed vedolizumab biosimilar, PB016

Polpharma Biologics & Fresenius Kabi enter licensing agreement for proposed vedolizumab biosimilar, PB016: Amsterdam Wednesday, August 6, 2025, 11:00 Hrs [IST] Polpharma Biologics ...
Pharmabiz6h

Ascletis completes enrollment in US phase IIa study of small molecule oral GLP-1R agonist, ASC30 to treat obesity

Ascletis completes enrollment in US phase IIa study of small molecule oral GLP-1R agonist, ASC30 to treat obesity: Hong Kong Wednesday, August 6, 2025, 10:00 Hrs [IST] Ascletis Ph ...
Pharmabiz7h

BD businesses become first in medtech to achieve HIRC's Diamond Badge across all supply chain resiliency categories

BD businesses become first in medtech to achieve HIRC's Diamond Badge across all supply chain resiliency categories: Franklin Lakes, New Jersey Wednesday, August 6, 2025, 09:00 Hr ...